Glitanir M Tablet Substitute
RXSystopic Laboratories Pvt Ltd
₹70
(₹4.2 per unit)
RXMankind Pharma Pvt Ltd
₹64.5
(₹5.81 per unit)
RXDaylon healthcare pvt Ltd
₹84
(₹7.56 per unit)
RXVaks Pharma Pvt Ltd
₹132.5
(₹7.95 per unit)
RXMankind Pharma Pvt Ltd
₹94.5
(₹8.51 per unit)
RXJarun Pharmaceuticals Pvt Ltd
₹97.5
(₹8.78 per unit)
RXFranco Indian Pharmaceuticals Pvt Ltd
₹100
(₹9.0 per unit)
RXEris Life Sciences Ltd
₹100
(₹9.0 per unit)
RXMicro Labs Ltd
₹102
(₹9.18 per unit)
RXIpca Laboratories Ltd
₹121.5
(₹10.94 per unit)
RXWockhardt Ltd
₹193.5
(₹11.61 per unit)
RXTorrent Pharmaceuticals Ltd
₹129.5
(₹11.66 per unit)
RXSun Pharmaceutical Industries Ltd
₹143
(₹12.88 per unit)
RXUSV Pvt Ltd
₹145.5
(₹13.1 per unit)
RXLupin Ltd
₹152.5
(₹13.73 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Glitanir M Tablet to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - METFORMIN-500MG + PIOGLITAZONE-15MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Glitanir M Tablet is used in the treatment of type 2 diabetes. The detailed uses of Glitanir M Tablet are as follows:
The substitutes of Glitanir M Tablet contain the same active salt(s) - METFORMIN-500MG + PIOGLITAZONE-15MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Glitanir M Tablet is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Glitanir M Tablet are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Glitanir M Tablet meet the same safety and efficacy standards as Glitanir M Tablet , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Glitanir M Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Glitanir M Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Glitanir M Tablet for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Glitanir M Tablet is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Glitanir M Tablet to its substitute. Always consult your doctor before switching.
Glitanir M Tablet is used to treat Type II diabetes (non-insulin-dependent diabetes). It lowers blood sugar by activating cell switches (PPAR) to take up free glucose from the blood and use it for energy production. It also decreases the production of glucose in the liver.
Glitanir M Tablet can cause fluid retention, which can cause heart failure. The doctor usually recommends starting from a lower dose and increasing the dose slowly while treating patients who are at risk of heart failure. Heart failure is reported mainly in patients taking insulin Glitanir M Tablet simultaneously.
There have been rare cases of liver damage in patients taking Glitanir M Tablet . The doctor usually screens the patient continuously during the course of treatment with Glitanir M Tablet . A patient is advised to visit a doctor strictly as per the doctor's advice.
Glitanir M Tablet is contradictory when used in patients with high blood pressure. A doctor's consultation is required before taking this drug in a patient with high blood pressure.
Glitanir M Tablet is safe to take before driving a vehicle or operating machinery, provided blood sugar levels are stable. However, a patient is advised to take proper precautions and make sure that Glitanir M Tablet is not taken with another blood sugar-lowering agent.
Not recommended to be taken with contraceptives. Glitanir M Tablet decreases the activity of oral contraceptives like Ethinyl estradiol by almost 30% and leads to failure of contraception.
Type 2 diabetes is a condition where the body is unable to produce sufficient insulin, or the insulin it produces doesn't work correctly or is not utilised by the body. This can cause high blood sugar levels (hyperglycemia). Symptoms of type 2 diabetes include increased thirst, frequent urination, slow, increased hunger, fatigue, and blurred vision.
Glitanir M Tablet should be swallowed as a whole with a glass of water. Avoid crushing, chewing, or breaking it.
Don't stop taking Glitanir M Tablet without consulting your doctor, even if your blood sugar levels return to normal. Stopping the medication suddenly can cause your blood sugar levels to fluctuate, leading to potential complications. Your doctor prescribed Glitanir M Tablet to help manage your type 2 diabetes, and they need to assess your condition before making any changes to your treatment plan. Consult your doctor before stopping or adjusting your medication, as they will provide personalised guidance to ensure your blood sugar levels remain stable and under control.
Avoid or limit alcohol consumption while taking Glitanir M Tablet , as it can interact with the medication and increase the risk of low or high blood sugar levels, as well as a rare but serious condition called lactic acidosis. Additionally, alcohol can worsen certain health conditions, such as nerve damage or liver disease. If you do choose to drink alcohol, do so in moderation and closely monitor your blood sugar levels.
Common side effects of Glitanir M Tablet may include stomach aches, feeling sick (nausea), vomiting, diarrhoea, loss of appetite, localised swelling (oedema), weight gain, headache, respiratory infection, numbness, taste disturbance, etc. Most of these side effects of Glitanir M Tablet do not require medical attention and typically resolve on their own over time. However, if the side effects persist or worsen, please consult your doctor.
To make an informed decision, consult your healthcare professional, who can assess your individual situation and provide personalised guidance on using Glitanir M Tablet while breastfeeding.
Glitanir M Tablet should be taken with caution in patients with kidney disease. In rare cases, serious interactions have been found in kidney patients, called lactic acidosis; thus, a doctor's consultation is required before taking Glitanir M Tablet .
Glitanir M Tablet is recommended not to be used in children. Glitanir M Tablet is a medication typically prescribed for adults over 18 years with type 2 diabetes.
Glitanir M Tablet is not recommended during pregnancy as there is not much information about its safety during pregnancy. If you are pregnant or thinking of getting pregnant, talk to your doctor, as they will need to review your treatment. They can suggest a different medicine that is safer for you to take during pregnancy.
Store in a cool and dry place away from sunlight. Keep Glitanir M Tablet out of reach and out of sight to children.
No, Glitanir M Tablet is not indicated for treating type 1 diabetes. Glitanir M Tablet is a medication specifically designed to treat type 2 diabetes, and it's not suitable for managing type 1 diabetes.
Glitanir M Tablet can interact with various other drugs, including those used to manage diabetes, blood pressure, heart conditions, and thyroid disorders, as well as steroids and blood thinners. Always let your healthcare professional know about all the medications you are currently taking to reduce risks. They will help you navigate potential interactions and ensure safe treatment. Consulting your healthcare professional before combining Glitanir M Tablet with any other medications is key.
Glitanir M Tablet contains Pioglitazone (thiazolidinedione) & Metformin (biguanide).
Buy best Diabetics products by
Torrent Pharmaceuticals Ltd
Intas Pharmaceuticals Ltd
Eris Life Sciences Ltd
Lupin Ltd
Micro Labs Ltd
Sun Pharmaceutical Industries Ltd
Mankind Pharma Pvt Ltd
Alkem Laboratories Ltd
Lloyd Healthcare Pvt Ltd
Cipla Ltd
Macleods Pharmaceuticals Ltd
Abbott India Ltd
Primus Remedies Pvt Ltd
Glenmark Pharmaceuticals Ltd
Aristo Pharmaceuticals Pvt Ltd
Dr Reddy's Laboratories Ltd
USV Pvt Ltd
La Renon Healthcare Pvt Ltd
Wockhardt Ltd
Emcure Pharmaceuticals Ltd
Fusion Health Care Pvt Ltd
Ajanta Pharma Ltd
Ipca Laboratories Ltd
Alembic Pharmaceuticals Ltd
Corona Remedies Pvt Ltd
East West Pharma India Pvt Ltd
Hbc Life Sciences Pvt Ltd
Eswar Therapeutics Pvt Ltd
Zydus Healthcare Ltd
Alteus Biogenics Pvt Ltd
Elbrit Life Sciences Pvt Ltd
Mitoch Pharma Pvt Ltd
Medley Pharmaceuticals Ltd
Ranmarc Labs
Sinsan Pharmaceuticals Pvt Ltd
Msn Laboratories Pvt Ltd
Nirvana India Pvt Ltd
Tas Med India Pvt Ltd
Akumentis Healthcare Ltd
Arkas Pharma Pvt Ltd
Unison Pharmaceuticals Pvt Ltd
Leeford Healthcare Ltd
Acmedix Pharma Llp
Sanofi India Ltd
Q Check Pharmaceuticals
Novo Nordisk India Pvt Ltd
Blue Cross Laboratories Pvt Ltd
Xemex Life Sciences
Neucure Lifesciences Pvt Ltd
Alvio Pharmaceuticals Pvt Ltd
Anthem Bio Pharma
Spectra Therapeutics Pvt Ltd
Sydmen Life Sciences Pvt Ltd
Aareen Healthcare Pvt Ltd
Diacardus Pharmacy Pvt Ltd
Jubilant Lifesciences Ltd
Talent India Pvt Ltd
Edoc Life Sciences Pvt Ltd
Stature Life Sciences Pvt Ltd
Systopic Laboratories Pvt Ltd
Panacea Biotec Ltd
Sanz Pharmaceuticals
Shrrishti Health Care Products Pvt Ltd
Verse Lifesciences
Akesiss Pharma Pvt Ltd
Franco Indian Pharmaceuticals Pvt Ltd
Hicxica Formulations Pvt Ltd
Indoco Remedies Ltd
Lividus Pharmaceuticals Pvt Ltd
Capital Pharma
Elinor Pharmaceuticals (P) Ltd
Saan Labs
Zydus Cadila
Biocon Ltd
Eli Lilly and Company (India) Pvt Ltd
Lippon Pharma Pvt Ltd
MERAKI HEALTH
Remedy Life Sciences Pvt Ltd
Koye Pharmaceuticals Pvt Ltd
Morepen Laboratories Ltd
Eysys Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Atos Lifesciences Pvt Ltd
Azkka Pharmaceuticals Pvt Ltd
Converge Biotech Pvt Ltd
Erinyle Health Care Pvt Ltd
Elder Pharmaceuticals Ltd
FDC Ltd
Heal (India) Laboratories Pvt Ltd
Knoll Healthcare Pvt Ltd
Jarun Pharmaceuticals Pvt Ltd
Opsis Care Lifesciences Pvt Ltd
Vasu Organics Pvt Ltd
Wallace Pharmaceuticals Pvt Ltd
CADOMAX HEALTHCARE PVT. LTD
Cadomed Pharmaceuticals India Pvt Ltd
Daylon healthcare pvt Ltd
Lincoln Pharmaceuticals Ltd
Medicure Life Sciences Pvt Ltd
Olcare Laboratories Pvt Ltd